Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
Shurong Ma(Dalian Medical University), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hang Yu(Humboldt-Universität zu Berlin), Ran Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinbo Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Fujian Normal University), Lin Cong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Li(Jilin University), Jie Fu(Southwest Petroleum University), Zhengwei Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xianfeng Zhang(Jilin University), Pei Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenxiong Zhao(Shanghai Medical College of Fudan University), Qian Tong(Jilin University), Yuan Lin(Beth Israel Deaconess Medical Center), Li‐Bin Pan(Zhejiang Cancer Hospital)
Cited by 186
Related Papers
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
|Nature Medicine|1999|575
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
|Proceedings of the National Academy of Sciences|2009|444
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
|Signal Transduction and Targeted Therapy|2021|315